Finished Dosage Forms

We are pleased to be able to offer you a broad portfolio of Finished Dosage Forms, covering all therapeutic areas and various types of technologies.

At Galenicum Axium, we focus on three different lines of work. On the one hand, more innovative and complex developments based on our know-how acquired throughout the years in different types of pharmaceutical products. On the other hand, the development of products that will become off-patent in the next 10-20 years. And, finally, the improvement of our already existing portfolio. 

Contact our team for further information on our portfolio!

ALIMENTARY TRACT AND METABOLISM

PRODUCTS

  • Dossier available

    Almagate

    Available dosages:

    1500 mg liquid stick pack

    500 mg tablets

  • Dossier available

    Canagliflozin

    Available dosages:

    100 & 300 mg tablets

  • Dossier available

    Canagliflozin/Metformin

    Available dosages:

    50/500 mg, 50/1000 mg, 150/500 mg & 150/1000 mg tablets

  • Dossier available

    Cinitapride

    Available dosages:

    1 mg tablets

  • Dossier available

    Dapagliflozin

    Available dosages:

    5 & 10 mg tablets

  • Dossier available

    Dapagliflozin/Metformin

    Available dosages:

    5/850 & 5/1000mg tablets

  • Dossier available

    Empagliflozin

    Available dosages:

    10 & 25 mg tablets

  • Dossier available

    Empagliflozin/Metformin

    Available dosages:

    5/500, 5/850, 5/1000, 12.5/500, 12.5/850 & 12.5/1000mg tablets

  • Dossier available

    Empagliflozin/Linagliptin

    Available dosages:

    10 & 25 mg tablets

  • Dossier available

    Linagliptin

    Available dosages:

    5mg tablets

  • Dossier available

    Linagliptin/Metformin

    Available dosages:

    2.5/850 mg & 2.5/1000 mg

  • Dossier available

    Liraglutide

    Available dosages:

    0.6, 1.2 & 1.8mg & 0.6, 1.2, 1.8, 2.4 & 3mg pre-filled cartridge pen

  • Dossier available

    Metformin

    Available dosages:

    500, 850 & 1000 mg tablets

  • Dossier available

    Semaglutide

    Available dosages:

    2mg/1.5mL (1.34 mg/mL) pre-filled cartridge pen

  • Dossier available

    Setmelanotide acetate

    Available dosages:

    10 mg/mL solution for injection

  • Dossier available

    Sitagliptin

    Available dosages:

    25, 50 & 100 mg tablets

  • Dossier available

    Sitagliptin/Metformin

    Available dosages:

    50/1000 mg, 50/850 mg & 50/500 mg tablets

  • Dossier available

    Tirzepatide

    Available dosages:

    2.5, 5, 7.5, 10, 12.5 & 15mg/0.5mL pre-filled cartridge pen

  • Dossier available

    Vildagliptin

    Available dosages:

    50 mg tablets

  • Dossier available

    Vildagliptin/Metformin

    Available dosages:

    50/850 mg & 50/1000 mg tablets

  • Dossier available

    Vonoprazan

    Available dosages:

    10 & 20mg tablets

Blood and blood forming organs

PRODUCTS

  • Dossier available

    Cilostazol

    Available dosages:

    100 mg tablets

  • Dossier available

    Dabigatran

    Available dosages:

    75, 110 & 150 mg capsules

  • Dossier available

    Eltrombopag

    Available dosages:

    12.5, 25, 50 & 75mg + 100mg tablets

Cardiovascular system

PRODUCTS

  • Dossier available

    Amiodarone*

    Available dosages:

    150mg/100mL (1.8mg/mL) & 360mg/200mL (1.5mg/mL) infusion bag

  • Dossier available

    Bempedoic Acid

    Available dosages:

    180mg tablets

  • Dossier available

    Rosuvastatin

    Available dosages:

    5, 10, 20 & 40 mg tablets

  • Dossier available

    Inclisiran

    Available dosages:

    284 mg/1.5mL (189 mg/mL) subcutaneous solution

  • Dossier available

    Atorvastatin

    Available dosages:

    10, 20, 30, 40, 60 & 80 mg tablets

Dermatologicals

PRODUCTS

  • Dossier available

    Betamethasone/Calcipotriol

    Available dosages:

    0.5 mg/g + 50 mcg/g gel

Genito urinary system

PRODUCTS

  • Dossier available

    Dutasteride

    Available dosages:

    0.5 mg soft gel capsules

  • Dossier available

    Dutasteride/Tamsulosin

    Available dosages:

    0.5/0.4 mg capsules

Anti-infectives for systemic use

PRODUCTS

  • Dossier available

    Caspofungin

    Available dosages:

    50 & 70 mg injection

  • Dossier available

    Micafungin

    Available dosages:

    50 & 100 mg injection

  • Dalbavancin

    Available dosages:

    500mg injection

  • Dossier available

    Tigecycline

    Available dosages:

    50 mg injection

  • Aztreonam*

    Available dosages:

    1g & 2g injection

  • Dossier available

    Tigecycline

    Available dosages:

    50 mg injection

  • Rezafungin

    Available dosages:

    200mg injection

Antineoplastic and immunomodulating agents

PRODUCTS

  • Dossier available

    Anagrelide

    Available dosages:

    0.5 & 1 mg capsuless

  • Dossier available

    Anastrozole

    Available dosages:

    1 mg tablets

  • Dossier available

    Voclosporin

    Available dosages:

    7.9mg capsules

  • Dossier available

    Letrozole

    Available dosages:

    2.5 mg tablets

  • Dossier available

    Midostaurin

    Available dosages:

    25mg soft gel capsules

  • Dossier available

    Motixafortide*

    Available dosages:

    EQ 62mg base/vial subcutaneous powder

  • Dossier available

    Ruxolitinib

    Available dosages:

    5, 10, 15, 20 & 25mg tablets

Musculo-skeletal system

PRODUCTS

  • Dossier available

    Dexketoprofen

    Available dosages:

    25 mg oral solution stick pack

    12.5 & 25 mg tablets

  • Dossier available

    Ibuprofen

    Available dosages:

    25 mg oral solution stick pack

    400mg, 600mg tablets

  • Dossier available

    Octreotide*

    Available dosages:

    10, 20 & 30 mg base/vial

  • Dossier available

    Vosoritide*

    Available dosages:

    20.4, 0.56 & 1.2mg powder

  • Dossier available

    Ibuprofen

    Available dosages:

    25 mg oral solution stick pack

    400mg, 600mg tablets

Nervous system

PRODUCTS

  • Dossier available

    Almotriptan

    Available dosages:

    12.5 mg tablets

  • Dossier available

    Citicoline

    Available dosages:

    500 mg/5 ml & 1 g/10 ml oral solution stick pack

  • Dossier available

    Diazepam

    Available dosages:

    10mg/2ml pre-filled syringes

    50mg/10ml vials

  • Dossier available

    Edaravone*

    Available dosages:

    30mg/100ml infusion bag

  • Dossier available

    Tafamidis free acid

    Available dosages:

    61mg soft gel capsules

  • Dossier available

    Tafamidis meglumine

    Available dosages:

    20mg soft gel capsules

  • Dossier available

    Paracetamol

    Available dosages:

    100mg/ml oral solution 30ml, 60ml & 90ml

    500, 650 & 1000mg tablets

  • Dossier available

    Rivastigmine

    Available dosages:

    2mg/ml - 120ml oral solution bottle

  • Dossier available

    Remimazolam

    Available dosages:

    20ml lyophilized powder for Injection

Respiratory system

PRODUCTS

  • Dossier available

    Azelastine

    Available dosages:

    1mg/ml - 10ml nasal spray bottle

Sensory system

PRODUCTS

  • Dossier available

    Fluorometholone*

    Available dosages:

    1mg/ml ophthalmic suspension

Various

PRODUCTS

  • Dossier available

    Indigotin disulfonate*

    Available dosages:

    40mg/5mL (8mg/mL) intraveneous solution

  • Dossier available

    Methylene blue*

    Available dosages:

    50mg/10mL & 10mg/2mL solution for injection

  • Dossier available

    Sugammadex

    Available dosages:

    200mg/2ml & 500mg/5ml injection

Thanks for reaching out. We will get back to you as soon as possible.

RESTRICTED ACCESS

The information contained in this section is aimed at the healthcare professional of the Pharmaceutical Industry, therefore, specialized training is required for its correct interpretation.

The products mentioned may have a different authorized data sheet in each country.

If you click the "accept" button, you are expressing your willingness to access the information explicitly intended for healthcare professionals.

DABIGAMAX

DEVELOPMENT OF THE FIRST GENERIC PHARMACEUTICAL SPECIALTY WITH DABIGATRAN. Decision EMC/2755/2017, dated November 20, (DOGC núm. 7508 of 30/11/2017) regarding the call for NUCLEUS OF INDUSTRIAL RESEARCH AND EXPERIMENTAL DEVELOPMENT (file number RD17-1-0006). This project has received funding from the European Union through the European Regional Development Fund (ERDF). With the collaboration from ACCIÓ.